2020 Conference

The IOTOD conference offers a range of exciting and interactive sessions, involving thought-provoking talks and expert-led panel discussions.

Virtual Summit 2020
Available to view on demand until Thursday 22 October

In light of ongoing restrictions to travel and public gatherings and our commitment to the safety of our delegates, exhibitors and staff, this year’s conference was delivered as a virtual experience.

The digital event delivered the same thought leadership and education via interactive seminars, workshops, satellite symposia, posters and a virtual exhibition. All content is now available to attendees and registrants for a further 30 days on-demand, allowing you to reflect on learnings or catch up on any missed sessions at your leisure.

If you have already registered for IOTOD 2020, you should have received an email confirming that your registration has been transferred and any next steps required. If you have not received this, please contact us on contact@iotodmeeting.com

WHAT WAS DISCUSSED AT IOTOD 2020?

  • Addressing challenges faced during opioid substitution therapy
  • Deconstructing stigma: recognising the needs of drug-using populations
  • Shining a light on opioid analgesic dependence
  • Long-acting buprenorphine formulations: a panoramic view
  • Strategies for improving viral hepatitis care among PWIDs
  • Complex cases: panel discussion

The European Accreditation Committee in CNS (EACIC) has granted 9 CME credits to this event. Information on how to obtain CME credits will be available once you have attended the event.

The IOTOD experience

 

Measuring behavioural changes

2011 marked the year measurement of delegate behavioural changes began. These measurements showed the IOTOD conference elicited measurable significant improvements in physician behaviours over the years, which have been published in the European Journal of CME.

Download

IOTOD’s commitment to change

Webcasts

Manoeuvres in the fog: drug-drug interactions in OST
Practicalities of transitioning between opioid agonist treatments
New horizons for treatment: translating the latest research into clinical practice
Tailoring behavioural interventions: emerging evidence and practical implications
View all webcasts